Literature DB >> 29328338

Binding affinity prediction of nanobody-protein complexes by scoring of molecular dynamics trajectories.

Miguel A Soler1, Sara Fortuna, Ario de Marco, Alessandro Laio.   

Abstract

Nanobodies offer a viable alternative to antibodies for engineering high affinity binders. Their small size has an additional advantage: it allows exploiting computational protocols for optimizing their biophysical features, such as the binding affinity. The efficient prediction of this quantity is still considered a daunting task especially for modelled complexes. We show how molecular dynamics can successfully assist in the binding affinity prediction of modelled nanobody-protein complexes. The approximate initial configurations obtained by in silico design must undergo large rearrangements before achieving a stable conformation, in which the binding affinity can be meaningfully estimated. The scoring functions developed for the affinity evaluation of crystal structures will provide accurate estimates for modelled binding complexes if the scores are averaged over long finite temperature molecular dynamics simulations.

Mesh:

Substances:

Year:  2018        PMID: 29328338     DOI: 10.1039/c7cp08116b

Source DB:  PubMed          Journal:  Phys Chem Chem Phys        ISSN: 1463-9076            Impact factor:   3.676


  10 in total

1.  Computational Evolution Protocol for Peptide Design.

Authors:  Rodrigo Ochoa; Miguel A Soler; Ivan Gladich; Anna Battisti; Nikola Minovski; Alex Rodriguez; Sara Fortuna; Pilar Cossio; Alessandro Laio
Journal:  Methods Mol Biol       Date:  2022

2.  Protocol for iterative optimization of modified peptides bound to protein targets.

Authors:  Rodrigo Ochoa; Pilar Cossio; Thomas Fox
Journal:  J Comput Aided Mol Des       Date:  2022-10-19       Impact factor: 4.179

3.  Computational Evolution of Beta-2-Microglobulin Binding Peptides for Nanopatterned Surface Sensors.

Authors:  Abimbola Feyisara Adedeji Olulana; Miguel A Soler; Martina Lotteri; Hendrik Vondracek; Loredana Casalis; Daniela Marasco; Matteo Castronovo; Sara Fortuna
Journal:  Int J Mol Sci       Date:  2021-01-15       Impact factor: 5.923

4.  Effect of Humanizing Mutations on the Stability of the Llama Single-Domain Variable Region.

Authors:  Miguel A Soler; Barbara Medagli; Jiewen Wang; Sandra Oloketuyi; Gregor Bajc; He Huang; Sara Fortuna; Ario de Marco
Journal:  Biomolecules       Date:  2021-01-26

Review 5.  VHH Structural Modelling Approaches: A Critical Review.

Authors:  Poonam Vishwakarma; Akhila Melarkode Vattekatte; Nicolas Shinada; Julien Diharce; Carla Martins; Frédéric Cadet; Fabrice Gardebien; Catherine Etchebest; Aravindan Arun Nadaradjane; Alexandre G de Brevern
Journal:  Int J Mol Sci       Date:  2022-03-28       Impact factor: 5.923

6.  In Silico Maturation of a Nanomolar Antibody against the Human CXCR2.

Authors:  Damiano Buratto; Yue Wan; Xiaojie Shi; Guang Yang; Francesco Zonta
Journal:  Biomolecules       Date:  2022-09-13

Review 7.  Recombinant expression of nanobodies and nanobody-derived immunoreagents.

Authors:  Ario de Marco
Journal:  Protein Expr Purif       Date:  2020-04-11       Impact factor: 1.650

8.  Enhanced Conformational Sampling of Nanobody CDR H3 Loop by Generalized Replica-Exchange with Solute Tempering.

Authors:  Ren Higashida; Yasuhiro Matsunaga
Journal:  Life (Basel)       Date:  2021-12-18

9.  CDR1 Composition Can Affect Nanobody Recombinant Expression Yields.

Authors:  Marco Orlando; Sara Fortuna; Sandra Oloketuyi; Gregor Bajc; Adi Goldenzweig; Ario de Marco
Journal:  Biomolecules       Date:  2021-09-14

10.  Research Progress and Applications of Multivalent, Multispecific and Modified Nanobodies for Disease Treatment.

Authors:  Jiewen Wang; Guangbo Kang; Haibin Yuan; Xiaocang Cao; He Huang; Ario de Marco
Journal:  Front Immunol       Date:  2022-01-18       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.